Squarepoint
PRCT icon

Squarepoint’s Procept Biorobotics PRCT Stock Holding History

Squarepoint’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$744K Buy
40,816
+14,386
+54% +$287K ﹤0.01% 3044
2026
Q2 		$597K Buy
+26,430
New +$662K ﹤0.01% 3286
2026
Q1 		– Sell
-191,581
Closed -$6.03M – 4816
2025
Q4 		$6.03M Buy
+191,581
New +$6.35M 0.01% 1341
2025
Q3 		– Sell
-159,600
Closed -$7.29M – 4857
2025
Q2 		$9.19M Sell
159,600
-61,669
-28% -$3.49M 0.01% 1112
2025
Q1 		$12.9M Buy
221,269
+129,494
+141% +$8.84M 0.02% 904
2024
Q4 		$7.39M Buy
91,775
+15,484
+20% +$1.32M 0.01% 1338
2024
Q3 		$6.11M Buy
76,291
+29,818
+64% +$2.12M 0.01% 1277
2024
Q2 		$2.84M Buy
46,473
+12,077
+35% +$718K ﹤0.01% 1788
2024
Q1 		$1.7M Buy
34,396
+27,531
+401% +$1.31M ﹤0.01% 2194
2023
Q4 		$288K Sell
6,865
-22,517
-77% -$767K ﹤0.01% 3390
2023
Q3 		$964K Buy
+29,382
New +$1M ﹤0.01% 2344
2023
Q2 		– Sell
-52,746
Closed -$1.5M – 3910
2023
Q1 		$1.5M Buy
52,746
+25,980
+97% +$916K 0.01% 1615
2022
Q4 		$1.11M Buy
+26,766
New +$1.15M ﹤0.01% 1748
2021
Q4 		– Sell
-26,549
Closed -$1.01M – 3449
2021
Q3 		$1.01M Buy
+26,549
New +$1.02M ﹤0.01% 1556

Other funds holding PRCT

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Champlain Investment Partners
Champlain Investment Partners Burlington, Vermont $2.9B AUM 23.58% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Rhenman & Partners Asset Management
Rhenman & Partners Asset Management Stockholm, Sweden $903M AUM 49.67% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Squarepoint's PRCT Position: Q3 2026 in Review

Squarepoint increased its Procept Biorobotics (PRCT) stake by 54% in Q3 2026, buying an estimated $287K and bringing the position to 40,816 shares worth $744K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Squarepoint first reported a position in PRCT in Q3 2021 and has held it in 14 quarters since. The position peaked at $12.9M in Q1 2025. 137 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Squarepoint held 40,816 shares of Procept Biorobotics worth $744K as of Q3 2026.
  • Squarepoint bought 14,386 Procept Biorobotics shares in Q3 2026, an estimated $287K.
  • Procept Biorobotics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3044 holding.
  • Squarepoint first reported a position in Procept Biorobotics in Q3 2021 and has held it in 14 quarters since.
  • Squarepoint's Procept Biorobotics position peaked at $12.9M in Q1 2025.
  • 137 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.